India’s Drugs Controller General has recently approved PresVu, an innovative eye drop from Entod Pharmaceuticals designed to address presbyopia, a common age-related condition affecting the eye’s ability to focus on nearby objects. PresVu is India’s first approved eye drop specifically aimed at treating this condition, marking a significant step forward in eye care.
What is Presbyopia?
Presbyopia typically affects individuals over the age of 40, causing difficulty in reading or focusing on close objects. It occurs naturally as the eye’s lens loses elasticity, which makes it harder to focus on nearby items. Globally, it is estimated that between 1.09 billion to 1.80 billion people suffer from presbyopia.
How Does PresVu Work?
PresVu has been formulated using advanced dynamic buffer technology, which enables it to adapt quickly to the eye’s pH levels and provide sustained benefits. The eye drop enhances near vision within 15 minutes of application, offering an alternative to reading glasses or contact lenses. In addition to improving vision, PresVu also lubricates and protects the eyes, ensuring long-lasting relief.
Key Benefits:
- Improves near vision within 15 minutes.
- Provides a non-invasive alternative to reading glasses.
- Lubricates the eyes for added comfort.
- Long-lasting effect thanks to advanced dynamic buffer technology.
Clinical Potential
Experts such as Dr. Aditya Sethi and Dr. Dhananjay Bakhle believe that PresVu could transform the treatment of presbyopia. By offering a simple, non-invasive option, this breakthrough could significantly improve the quality of life for millions who depend on reading glasses for daily activities.
Leave a Reply